News
Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.30 crore in the September 2024 quarter
11-Nov-2024 | 16:52
Sales reported at Rs 0.17 crore
Net Loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.30 crore in the quarter ended September 2024 as against net loss of Rs 0.03 crore during the previous quarter ended September 2023. Sales reported to Rs 0.17 crore in the quarter ended September 2024. There were no Sales reported during the previous quarter ended September 2023.
| Particulars | Quarter Ended | ||
| Sep. 2024 | Sep. 2023 | % Var. | |
| Sales | 0.17 | 0 | 0 |
| OPM % | -176.47 | 0 | - |
| PBDT | -0.30 | -0.03 | -900 |
| PBT | -0.30 | -0.03 | -900 |
| NP | -0.30 | -0.03 | -900 |
Powered by Capital Market - Live News